Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 2/20 | 0.50 |
| ▸ | BRD4 | O60885 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | OGA | O60502 | 2/20 | 0.38 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7916564 | 1.00 | CREBBP (0.50) | CREBBPBRD4TDP1ACHEALDH1A1 | |
| SCHEMBL15667383 | 0.84 | TDP1 (0.57) | CREBBPBRD4TDP1ALDH1A1GAA | |
| SCHEMBL318360 | 0.84 | TDP1 (0.57) | CREBBPBRD4TDP1ALDH1A1GAA | |
| SCHEMBL15667344 | 0.84 | TDP1 (0.57) | CREBBPBRD4TDP1ALDH1A1GAA | |
| SCHEMBL10262750 | 0.81 | CREBBP (0.41) | CREBBPBRD4ACHEALDH1A1AKR1B1 | |
| SCHEMBL13475983 | 0.81 | ACHE (0.40) | CREBBPBRD4ACHEALDH1A1AKR1B1 | |
| SCHEMBL14449384 | 0.81 | ACHE (0.40) | CREBBPBRD4ACHEALDH1A1AKR1B1 | |
| SCHEMBL27541843 | 0.80 | MAOB (0.39) | CREBBPBRD4ACHEALDH1A1AKR1B1 | |
| SCHEMBL5547658 | 0.78 | ALDH1A1 (0.47) | CREBBPBRD4TDP1ALDH1A1GAA | |
| SCHEMBL18114486 | 0.78 | PBRM1 (0.56) | TDP1ALDH1A1GAASMN1; SMN2AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200029565-A1 | 2-AMINO-5-OXYALKYL-PYRIMIDINE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH | BAYER AKTIENGESELLSCHAFT (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200029565-A1 | 2-AMINO-5-OXYALKYL-PYRIMIDINE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH | PFAS, ODC1, GART | CREBBP 4129/4885BRD4 4281/4885TDP1 1509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.